BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30456413)

  • 1. The current status of alternative methods for cosmetics safety assessment in China.
    Luo FY; Su Z; Wu J; Zhang FL; Xing SX; Wang GL; Lu Y
    ALTEX; 2019; 36(1):136-139. PubMed ID: 30456413
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
    Rogiers V
    Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
    [No Abstract]   [Full Text] [Related]  

  • 3. Towards an integrated in vitro strategy for repeated dose toxicity testing.
    Vanhaecke T; Pauwels M; Vinken M; Ceelen L; Rogiers V
    Arch Toxicol; 2011 May; 85(5):365-6. PubMed ID: 21512801
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
    Pauwels M; Rogiers V
    Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of non-animal alternatives in the safety evaluations of cosmetics ingredients by the Scientific Committee on Consumer Safety (SCCS).
    Vinardell MP
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):198-204. PubMed ID: 25555996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30-31 March 2021, SCCS/1628/21.
    ;
    Regul Toxicol Pharmacol; 2021 Dec; 127():105052. PubMed ID: 34653552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010.
    Adler S; Basketter D; Creton S; Pelkonen O; van Benthem J; Zuang V; Andersen KE; Angers-Loustau A; Aptula A; Bal-Price A; Benfenati E; Bernauer U; Bessems J; Bois FY; Boobis A; Brandon E; Bremer S; Broschard T; Casati S; Coecke S; Corvi R; Cronin M; Daston G; Dekant W; Felter S; Grignard E; Gundert-Remy U; Heinonen T; Kimber I; Kleinjans J; Komulainen H; Kreiling R; Kreysa J; Leite SB; Loizou G; Maxwell G; Mazzatorta P; Munn S; Pfuhler S; Phrakonkham P; Piersma A; Poth A; Prieto P; Repetto G; Rogiers V; Schoeters G; Schwarz M; Serafimova R; Tähti H; Testai E; van Delft J; van Loveren H; Vinken M; Worth A; Zaldivar JM
    Arch Toxicol; 2011 May; 85(5):367-485. PubMed ID: 21533817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: eye irritation.
    McNamee P; Hibatallah J; Costabel-Farkas M; Goebel C; Araki D; Dufour E; Hewitt NJ; Jones P; Kirst A; Le Varlet B; Macfarlane M; Marrec-Fairley M; Rowland J; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):197-209. PubMed ID: 19393279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
    Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: genotoxicity. A COLIPA analysis.
    Pfuhler S; Kirst A; Aardema M; Banduhn N; Goebel C; Araki D; Costabel-Farkas M; Dufour E; Fautz R; Harvey J; Hewitt NJ; Hibatallah J; Carmichael P; Macfarlane M; Reisinger K; Rowland J; Schellauf F; Schepky A; Scheel J
    Regul Toxicol Pharmacol; 2010; 57(2-3):315-24. PubMed ID: 20382194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cosmetic products and their current European regulatory framework.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():1-28. PubMed ID: 18806452
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety assessment of cosmetics in Europe. Preface.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():XVII-XX. PubMed ID: 19177695
    [No Abstract]   [Full Text] [Related]  

  • 13. Current opinion on risk assessment of cosmetics.
    Kim KB; Kwack SJ; Lee JY; Kacew S; Lee BM
    J Toxicol Environ Health B Crit Rev; 2021 May; 24(4):137-161. PubMed ID: 33832410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges related to cosmetic safety assessment in the EU.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():29-57. PubMed ID: 18806453
    [No Abstract]   [Full Text] [Related]  

  • 15. Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients.
    Dent MP; Vaillancourt E; Thomas RS; Carmichael PL; Ouedraogo G; Kojima H; Barroso J; Ansell J; Barton-Maclaren TS; Bennekou SH; Boekelheide K; Ezendam J; Field J; Fitzpatrick S; Hatao M; Kreiling R; Lorencini M; Mahony C; Montemayor B; Mazaro-Costa R; Oliveira J; Rogiers V; Smegal D; Taalman R; Tokura Y; Verma R; Willett C; Yang C
    Regul Toxicol Pharmacol; 2021 Oct; 125():105026. PubMed ID: 34389358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An expert consortium review of the EC-commissioned report "alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010".
    Hartung T; Blaauboer BJ; Bosgra S; Carney E; Coenen J; Conolly RB; Corsini E; Green S; Faustman EM; Gaspari A; Hayashi M; Wallace Hayes A; Hengstler JG; Knudsen LE; Knudsen TB; McKim JM; Pfaller W; Roggen EL
    ALTEX; 2011; 28(3):183-209. PubMed ID: 21993956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of alternative methods in the safety assessment of cosmetic ingredients.
    Rogiers V; Pauwels M
    Curr Probl Dermatol; 2008; 36():129-65. PubMed ID: 18806457
    [No Abstract]   [Full Text] [Related]  

  • 18. The 7th Amendment to the Cosmetics Directive.
    Ruet Rossignol M
    Altern Lab Anim; 2005 Jul; 33 Suppl 1():19-20. PubMed ID: 16194137
    [No Abstract]   [Full Text] [Related]  

  • 19. The feasibility of replacing animal testing for assessing consumer safety: a suggested future direction.
    Fentem J; Chamberlain M; Sangster B
    Altern Lab Anim; 2004 Dec; 32(6):617-23. PubMed ID: 15757499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The way forward for assessing the human health safety of cosmetics in the EU - Workshop proceedings.
    Rogiers V; Benfenati E; Bernauer U; Bodin L; Carmichael P; Chaudhry Q; Coenraads PJ; Cronin MTD; Dent M; Dusinska M; Ellison C; Ezendam J; Gaffet E; Galli CL; Goebel C; Granum B; Hollnagel HM; Kern PS; Kosemund-Meynen K; Ouédraogo G; Panteri E; Rousselle C; Stepnik M; Vanhaecke T; von Goetz N; Worth A
    Toxicology; 2020 Apr; 436():152421. PubMed ID: 32119890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.